Notably, we found that levels of FGF21, but not FGF19, were significantly higher in plasma from IUGR than NW fetal littermates (Fig. 8A), suggesting that FGF21 may activate KLB to affect muscle development in IUGR fetuses. The gene discussed is FGF19; the disease is fetal growth restriction.